Hematology/Oncology

Top Story

Half of women with early-stage breast cancer consider prophylactic double mastectomy

Half of women with early-stage breast cancer consider prophylactic double mastectomy
August 23, 2017

A quarter of women with early-stage breast cancer and a favorable prognosis strongly considered undergoing contralateral prophylactic mastectomy, according to a study published in Cancer.

Another 29% of women considered the procedure either moderately or weakly, according to researchers.

In the Journals Plus

TAS-102, bevacizumab promising for refractory colorectal cancer

August 23, 2017
Trifluridine and tipiracil in combination with bevacizumab appeared safe and effective for the treatment of patients with metastatic colorectal cancer in the refractory…

Cancer network offers new resources for rectal cancer patients

August 23, 2017
The National Comprehensive Cancer Network has published new resources, including guidelines for patients and a quick guide sheet for rectal cancer – in addition to…
In the Journals Plus

Childhood chemotherapy may decrease cognitive function in young adults

August 23, 2017
Young adults who underwent chemotherapy for leukemia or lymphoma as children showed decreased cognitive flexibility and weaker short-term memory, according to a small…
In the Journals

Robotic-assisted esophageal surgery safe, effective for some patients

August 23, 2017
Robotic-assisted transhiatal esophagectomy was a safe and effective oncologic surgery in carefully selected patients, according to new research. The robotic technology…
More Headlines »
CME

The Patient with Pancreatic Cancer

No commercial support for this activity.

Pancreatic cancer only accounts for 3% of cancer cases, but it is the fourth leading cause of cancer-related death…
More »
Video
Meeting News

VIDEO: Results of LATITUDE trial reinforce long-hypothesized theory in prostate cancer treatment

June 21, 2017
More »
Resource Centers

CME

Multiple Myeloma Patient Management: Embracing New Advancements, Overcoming New Challenges

Support for this activity has been provided through educational grants from Amgen; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.

The multiple myeloma clinical landscape has evolved significantly, with not only 10 new drugs but also new staging…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement